{"ticker": {"uuid": "c3c46501-fae8-4d16-8d8f-8376b77ab040", "symbol": "NAVA", "name": "Navamedic ASA", "exchange": "OSL", "country": "NO", "sector": "Healthcare", "industry": "Medical Distribution"}, "articles": [{"title": "Nordea initiates coverage of Navamedic with a buy rating and a target price of 21 Norwegian kroner", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxOZGxUNjlWb2dTaE03RFV6UG9mWE5IY3Nvcm5NTE5BU0hqVkROSXZyTUp6MF94alRBU0tuZzNFYnBNVXAyY21YbF9fS09lZk9FN19adC1jcFdiSTVMWTdDRHQzZldkNHVOd2ctcmo3bHNzeDktcjZ1TVh3dzBMX3lUWUhNMlF4Zm1kenJiNHZRSF9LZXB1UkRRemY1Z1ZnaHU5NUd0cGUzTDFrT0Rod2djdnozX0NXb05DdHJBZ3VmSHV0RnhWWGlubVhTQlU4Q2hXVmJQN3Y4My1CVGVwQXJuOEdqeG9uUQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-03T05:42:16+00:00", "published_display": "03 Jul 2026 05:42", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Navamedic launches Virono\u00ae\u2013 the first single-dose over-the-counter cold sore tablet", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOUjhKWmZXc1hzeFEzRVBqMmxCajZ4TFNKanpONWxfTVFNcllzTEF6Z3RJNldmV0FtTDh4X2RKbF9TRWhzU1QxblN2aml3S1hfTlJGa21qOUhIeEttSE9Ka21odUtXVTJld25hLWNBY0xPdXRVNEdDZm83YUI4TTlRX2NfZm0zT00xcFlvZEJXMHlXUmtmRy1peV9hdUtYM1NKa3hiOGhxcWozQV9vRXZWd3dqQWZ5ck1PbXNmMGVPQXByQXR1djFTd1oxTQ?oc=5", "source_name": "Cision News", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Navamedic ASA: Broad launch for Eroxon\u00ae in Sweden today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOSDZBMGtQdGl5OVVJc1hCRXZzaEt4Ni0yWDNtUC0tYnRRTEVuTjE1Z2FqQ0VoeXR1T3JHNzNfLU1MazkzUTd1MWJwdi1hNHBsblhEV0VudEZZYmlRUVUyZUlQcUZMNGJaV1pxdWoxUTdVRGtVQlpWeTFlQmVoZC12LUZnXzNyc0Nvazd0REdkUkdTY0JGSFFiOUtZRDh2MUdZeTdrdk8zdw?oc=5", "source_name": "Cision News", "published_at": "2024-05-06T07:00:00+00:00", "published_display": "06 May 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Navamedic ASA launches Eroxon\u00ae", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQcEdxWm5neTBfcGduWXBzMXBadnl1TTFaTUJsS090SnFPVUpCdDBBbF95by1JbWdaRmY1RUY4YlhpQlVPa2lhRmc3anpKTWN0RC13SGV2RUtEYW5NLUh2MFlLaDdYVFFVdjZMNFp4UWwzNTM0RzN5OUZ6MGdTWTJuVnp6VExuQQ?oc=5", "source_name": "Cision News", "published_at": "2024-02-12T08:00:00+00:00", "published_display": "12 Feb 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Navamedic ASA: Enters into distribution agreement for ThermaCare\u00ae with Angelini Pharma", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxQVVd4QW1BT3JlR3phb2hhZVFHV01hYy1Hbk9aMzk0YnNXbUpTSXd4SmY1Vkx6V2NUSzRrVTBmd29FVFdQSFQzTXNFcEdDMmFWbnhFcnlEWmdfOExueldvcFMzMFNkQUNGYTIxd1Vxa0FlNWhmUk5GeXF1TlQ2bkhsWVlkaVhPZEU0eUhkZXZBblhhSy1WWmwzQlNTSHhlVHZFZC1nb3dMNmN4cGxrYTJWLVQyWDlZUDVQVXRtN0dXWkVveXAtdC12LUNZN041blA5?oc=5", "source_name": "Cision News", "published_at": "2020-03-31T07:00:00+00:00", "published_display": "31 Mar 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Nordea initiates coverage of Navamedic with a buy rating and a target price of 21 Norwegian kroner", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxOZGxUNjlWb2dTaE03RFV6UG9mWE5IY3Nvcm5NTE5BU0hqVkROSXZyTUp6MF94alRBU0tuZzNFYnBNVXAyY21YbF9fS09lZk9FN19adC1jcFdiSTVMWTdDRHQzZldkNHVOd2ctcmo3bHNzeDktcjZ1TVh3dzBMX3lUWUhNMlF4Zm1kenJiNHZRSF9LZXB1UkRRemY1Z1ZnaHU5NUd0cGUzTDFrT0Rod2djdnozX0NXb05DdHJBZ3VmSHV0RnhWWGlubVhTQlU4Q2hXVmJQN3Y4My1CVGVwQXJuOEdqeG9uUQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-03T05:42:16+00:00", "published_display": "03 Jul 2026 05:42", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Navamedic launches Virono\u00ae\u2013 the first single-dose over-the-counter cold sore tablet", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOUjhKWmZXc1hzeFEzRVBqMmxCajZ4TFNKanpONWxfTVFNcllzTEF6Z3RJNldmV0FtTDh4X2RKbF9TRWhzU1QxblN2aml3S1hfTlJGa21qOUhIeEttSE9Ka21odUtXVTJld25hLWNBY0xPdXRVNEdDZm83YUI4TTlRX2NfZm0zT00xcFlvZEJXMHlXUmtmRy1peV9hdUtYM1NKa3hiOGhxcWozQV9vRXZWd3dqQWZ5ck1PbXNmMGVPQXByQXR1djFTd1oxTQ?oc=5", "source_name": "Cision News", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Navamedic ASA: Broad launch for Eroxon\u00ae in Sweden today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOSDZBMGtQdGl5OVVJc1hCRXZzaEt4Ni0yWDNtUC0tYnRRTEVuTjE1Z2FqQ0VoeXR1T3JHNzNfLU1MazkzUTd1MWJwdi1hNHBsblhEV0VudEZZYmlRUVUyZUlQcUZMNGJaV1pxdWoxUTdVRGtVQlpWeTFlQmVoZC12LUZnXzNyc0Nvazd0REdkUkdTY0JGSFFiOUtZRDh2MUdZeTdrdk8zdw?oc=5", "source_name": "Cision News", "published_at": "2024-05-06T07:00:00+00:00", "published_display": "06 May 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Navamedic ASA launches Eroxon\u00ae", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQcEdxWm5neTBfcGduWXBzMXBadnl1TTFaTUJsS090SnFPVUpCdDBBbF95by1JbWdaRmY1RUY4YlhpQlVPa2lhRmc3anpKTWN0RC13SGV2RUtEYW5NLUh2MFlLaDdYVFFVdjZMNFp4UWwzNTM0RzN5OUZ6MGdTWTJuVnp6VExuQQ?oc=5", "source_name": "Cision News", "published_at": "2024-02-12T08:00:00+00:00", "published_display": "12 Feb 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Navamedic ASA: Enters into distribution agreement for ThermaCare\u00ae with Angelini Pharma", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxQVVd4QW1BT3JlR3phb2hhZVFHV01hYy1Hbk9aMzk0YnNXbUpTSXd4SmY1Vkx6V2NUSzRrVTBmd29FVFdQSFQzTXNFcEdDMmFWbnhFcnlEWmdfOExueldvcFMzMFNkQUNGYTIxd1Vxa0FlNWhmUk5GeXF1TlQ2bkhsWVlkaVhPZEU0eUhkZXZBblhhSy1WWmwzQlNTSHhlVHZFZC1nb3dMNmN4cGxrYTJWLVQyWDlZUDVQVXRtN0dXWkVveXAtdC12LUNZN041blA5?oc=5", "source_name": "Cision News", "published_at": "2020-03-31T07:00:00+00:00", "published_display": "31 Mar 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 75, "total_relevant": 5, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 4, "score": 53, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 76, "events": [{"event": "general", "label": "Market update", "weight": 2.2, "count": 4}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 16.4, "latest_week": "2026-07-10", "one_week_move": -3.5, "four_week_move": -2.1, "twelve_week_move": -23.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.405671, "market_dynamics_buy_signal": false, "relative_strength": -29.202336, "fair_value_gap": -40.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 39.5503, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.5% over one week, -2.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 60, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Cision News", "count": 4}, {"label": "marketscreener.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 4}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "76/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.5% over one week, -2.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Nordea initiates coverage of Navamedic with a buy rating and a target price of 21 Norwegian kroner"}], "updated_at": "2026-07-16T22:25:38.244882+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}